Patents Assigned to ZHONGSHAN OPHTHALMIC CENTER, SUN YAT-SEN UNIVERSITY
  • Patent number: 11420072
    Abstract: A method for increasing the blood flow and metabolic rate of the eye fundus by (1) irradiating the eye fundus through the pupil by using red light or near-infrared light in a certain wavelength range, a certain energy density range and a certain irradiation time range; (2) once irradiation is complete, repeating the irradiating at intervals of a certain time range, using red light or near-infrared light in the same wavelength range and the same energy density range to irradiate the eye fundus through the pupil.
    Type: Grant
    Filed: June 11, 2021
    Date of Patent: August 23, 2022
    Assignees: ZHONGSHAN OPHTHALMIC CENTER, SUN YAT-SEN UNIVERSITY, SUZHOU XUANJIA OPTICS AND ELECTRONICS TECHNOLOGY CO. LTD.
    Inventors: Mingguang He, Zhaoyun Cao, Zhuoting Zhu
  • Publication number: 20210402205
    Abstract: A method for increasing the blood flow and metabolic rate of the eye fundus by (1) irradiating the eye fundus through the pupil by using red light or near-infrared light in a certain wavelength range, a certain energy density range and a certain irradiation time range; (2) once irradiation is complete, repeating the irradiating at intervals of a certain time range, using red light or near-infrared light in the same wavelength range and the same energy density range to irradiate the eye fundus through the pupil.
    Type: Application
    Filed: June 11, 2021
    Publication date: December 30, 2021
    Applicants: ZHONGSHAN OPHTHALMIC CENTER, SUN YAT-SEN UNIVERSITY, SUZHOU XUANJIA OPTICS AND ELECTRONICS TECHNOLOGY CO. LTD.
    Inventors: Mingguang HE, Zhaoyun CAO, Zhuoting ZHU
  • Patent number: 11186819
    Abstract: Provided is a method of serum-free culturing corneal limbal stromal stem cells and inducing them to differentiate and form spheres. Also provide is a medium combination for inducing corneal limbal stromal stem cells to form spheres or differentiate into corneal limbal stromal cells in vitro. The serum-free medium combination used herein can provide sufficient nutrients and a good environment required for cell growth and proliferation, can provide a stable in vitro expansion of corneal limbal stromal stem cells and can ensure that the expanded corneal limbal stromal stem cells keep their stemness and specificity. In addition, a system for inducing them to differentiate into corneal limbal stromal cells is successfully built. It can be used in experimental studies of corneal limbal stromal stem cells, cell therapy of corneal lesions and transplant for corneal injury.
    Type: Grant
    Filed: October 16, 2018
    Date of Patent: November 30, 2021
    Assignee: ZHONGSHAN OPHTHALMIC CENTER, SUN YAT-SEN UNIVERSITY
    Inventors: Hong Ouyang, Liqiong Zhu
  • Patent number: 11062444
    Abstract: The invention relates to an artificial intelligence cataract analysis system, including a pattern recognition module for recognizing a photo mode of an input eye image, wherein the photo mode is divided according to the slit width of the illuminating slit during photographing of the eye image and/or whether a mydriatic treatment is carried out; a preliminary analysis module used for selecting a corresponding deep learning model for eye different photo modes, analyzing the characteristics of lens in the eye image by using a deep learning model, and further performing classification in combination with cause and severity degree of a disease. The invention can perform cataract intelligent analysis on eye images with different photo modes by using deep learning models, so that the analysis accuracy is improved.
    Type: Grant
    Filed: August 8, 2019
    Date of Patent: July 13, 2021
    Assignee: ZHONGSHAN OPHTHALMIC CENTER OF SUN YAT-SEN UNIVERSITY
    Inventors: Haotian Lin, Xiaohang Wu, Weiyi Lai
  • Publication number: 20210000454
    Abstract: Collection devices with valves for liquid specimens are disclosed. In an embodiment, the disclosure provides a collection device including a reservoir having a sealed cavity, the sealed cavity being under a negative pressure; a delivery tube in communication with the sealed cavity of the reservoir and having a delivery inlet, a delivery outlet, and a valve disposed between the delivery inlet and the delivery outlet, the valve being configured to control the communication and blocking between the delivery inlet and the delivery outlet, and an angle being formed by an extension line of the delivery inlet an extension line of the delivery outlet; and a piercing component for piercing a tissue is connected with the delivery inlet of the delivery tube.
    Type: Application
    Filed: May 30, 2018
    Publication date: January 7, 2021
    Applicant: Zhongshan Ophthalmic Center of Sun Yat-Sen University
    Inventors: Yizhi LIU, Yan LUO, Xiaofeng LIN, Lin LU
  • Patent number: 10738076
    Abstract: Disclosed are a lanosterol prodrug compound, a pharmaceutically acceptable salt and an isomer thereof, and a pharmaceutical composition comprising the lanosterol prodrug compound and the use thereof in the preparation of a drug for treating cataracts. The lanosterol prodrug compound has a better permeability than lanosterol.
    Type: Grant
    Filed: January 25, 2018
    Date of Patent: August 11, 2020
    Assignee: ZHONGSHAN OPHTHALMIC CENTER, SUN YAT-SEN UNIVERSITY
    Inventors: Yizhi Liu, Yandong Wang, Xiaolin Li, Zhi Luo, Liang Shen, Lijuan Hou, Xinxin Wen, Haiying He, Jian Li, Shuhui Chen
  • Publication number: 20200239842
    Abstract: Preparation and expansion methods for human pluripotent stem cell-derived human retinal pigment epithelial cells are provided. The preparation method includes the following steps: collecting 3D-PRE spheroids derived from human pluripotent stem cells, performing mechanical separation to remove non-RPE cells and clusters which are non-pigmented and retain a pigmented RPE cell sheet, enzymatically digesting the pigmented RPE cell sheet to obtain an RPE single cell suspension, and thereby the human pluripotent stem cell-derived human retinal pigment epithelial cells are obtained. The expansion method includes centrifuging the RPE single cell suspension and removing a supernatant, resuspending in an RPE cell medium and seeding into a cell culture container precoated with extracellular matrix to allow primary culture, and subculturing the cells after cells spread out.
    Type: Application
    Filed: April 28, 2018
    Publication date: July 30, 2020
    Applicant: ZHONGSHAN OPHTHALMIC CENTER, SUN YAT-SEN UNIVERSITY
    Inventors: Xiufeng ZHONG, Jian GE, Shengxu LIU, Fuhua PENG
  • Publication number: 20190256548
    Abstract: Disclosed are a lanosterol prodrug compound, a pharmaceutically acceptable salt and an isomer thereof, and a pharmaceutical composition comprising the lanosterol prodrug compound and the use thereof in the preparation of a drug for treating cataracts. The lanosterol prodrug compound has a better permeability than lanosterol.
    Type: Application
    Filed: January 25, 2018
    Publication date: August 22, 2019
    Applicant: ZHONGSHAN OPHTHALMIC CENTER, SUN YAT-SEN UNIVERSITY
    Inventors: Yizhi LIU, Yandong WANG, Xiaolin LI, Zhi LUO, Liang SHEN, Lijuan HOU, Xinxin WEN, Haiying HE, Jian LI, Shuhui CHEN
  • Publication number: 20160075708
    Abstract: Disclosed are an anti-abnormal proliferation of angiogenesis compound represented by formula I, use and intermediate thereof. The compound has good effect against abnormal proliferation of angiogenesis, and the activity of the compound is produced by inhibiting VEGFR2. The compound can be used for treating diseases, such as wet macular degeneration, inflammation, malignant tumor and the like, caused by abnormity of angiogenesis and protein kinases such as VEGFR2, FGFR2 and the like.
    Type: Application
    Filed: April 9, 2014
    Publication date: March 17, 2016
    Applicants: GUANGZHOU HUI BO RUI BIOLOGICAL PHARMACEUTICAL TECHNOLOGY CO., LTD., ZHONGSHAN OPHTHALMIC CENTER, SUN YAT-SEN UNIVERSITY
    Inventors: Rui Hou, Kang Zhang